PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma - Perry, J R; Julian, J A; Laperriere, N J (J Thromb Haemost, 2010)
, et al.